RAPT Therapeutics Stock Offering: Market Impact and Uncertainty
Update: 2025-10-21
Description
RAPT Therapeutics' stock dips as they announce a public offering to fund inflammatory disease therapies. Find out why this stock sale, managed by financial giants like Leerink Partners and Wells Fargo, has investors on edge, awaiting details on share price and quantity. Will this move fuel RAPT's research or further impact its market value?
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
